![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
R Corradetti, E Le Poul, N Laaris, M Hamon and L Lanfumey
Neurobiologie Cellulaire et Fonctionnelle, INSERM U 288, CHU Pitie- Salpetriere, Paris, France.
The aim of the present study was to examine the effects of N-(2-(4-2- methoxphenyl)-1-piperazinyl)ethyl)-N-(2-pyridnyl) cyclohexane carboxamide (WAY 100635) on 5-HT1A receptor-mediated responses in the dorsal raphe nucleus (DRN) and the CA1 hippocampal region. In DRN slices superfused with WAY 100635 (10 nM), the majority of putative 5- HT neurons increased their firing rate (13 +/- 2% of baseline rate). In addition, WAY 100635 completely prevented the decrease in firing rate produced by 5-HT (3-15 microM), 8-OH-DPAT (10 nM), 5- carboxamidotryptamine (20 nM) and lesopitron (100 nM). The antagonism exerted by WAY 100635 (IC50 = 0.95 +/- 0.12 nM against 15 microM 5-HT) was fully surmounted by increasing the concentration of 5-HT to 300 microM. In hippocampal slices, WAY 100635 (0.5-10 nM) did not alter the resting membrane potential or the membrane input resistance of intracellularly recorded CA1 pyramidal cells. However, WAY 100635 completely prevented (IC50 = 0.9-1.7 nM) the hyperpolarization and the decrease in membrane input resistance produced by 5-HT (15-30 microM) and by 5-carboxamidotryptamine (50-300 nM). In contrast, WAY 100635 affected neither the block of action potential frequency adaptation and slow afterhyperpolarization produced by 5-HT (15 microM) nor the hyperpolarization and decrease in membrane input resistance evoked by bath application of GABA(B) receptor agonist baclofen (10 microM). The cumulative concentration-hyperpolarization curve for 5- carboxamidotryptamine (3 nM-10 microM) was shifted to the right by WAY 100635 (apparent Kb = 0.23 +/- 0.07 nM), and the latter drug also reduced the maximal response to the agonist. These data show the WAY 100635 is a potent antagonist at 5-HT1A receptors, both in the DRN and in the CA1 region of the hippocampus. The antagonism is apparently competitive in the DRN and partly noncompetitive in the hippocampus. Kinetic characteristics of the antagonist-receptor interactions might account for these regional differences.
This article has been cited by other articles:
|
|
 |
|
  H. S. Orer, G. L. Gebber, and S. M. Barman Role of serotonergic input to the ventrolateral medulla in expression of the 10-Hz sympathetic nerve rhythm Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2008; 294(5): R1435 - R1444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Corradetti, B. Mlinar, C. Falsini, A. M. Pugliese, A. Cilia, C. Destefani, and R. Testa Differential Effects of the 5-Hydroxytryptamine (5-HT)1A Receptor Inverse Agonists Rec 27/0224 and Rec 27/0074 on Electrophysiological Responses to 5-HT1A Receptor Activation in Rat Dorsal Raphe Nucleus and Hippocampus in Vitro J. Pharmacol. Exp. Ther., October 1, 2005; 315(1): 109 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Riad, K. C. Watkins, E. Doucet, M. Hamon, and L. Descarries Agonist-Induced Internalization of Serotonin-1A Receptors in the Dorsal Raphe Nucleus (Autoreceptors) But Not Hippocampus (Heteroreceptors) J. Neurosci., November 1, 2001; 21(21): 8378 - 8386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kakizaki, M. Yoshiyama, T. Koyanagi, and W. C. De Groat Effects of WAY100635, a selective 5-HT1A-receptor antagonist on the micturition-reflex pathway in the rat Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2001; 280(5): R1407 - R1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Bacon and S. G. Beck 5-Hydroxytryptamine7 Receptor Activation Decreases Slow Afterhyperpolarization Amplitude in CA3 Hippocampal Pyramidal Cells J. Pharmacol. Exp. Ther., August 1, 2000; 294(2): 672 - 679. [Abstract] [Full Text]
|
|
|
|
|
|
E. Sibille, C. Pavlides, D. Benke, and M. Toth Genetic Inactivation of the Serotonin1A Receptor in Mice Results in Downregulation of Major GABAA Receptor alpha Subunits, Reduction of GABAA Receptor Binding, and Benzodiazepine-Resistant Anxiety J. Neurosci., April 15, 2000; 20(8): 2758 - 2765. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Testa, L. Guarneri, E. Poggesi, P. Angelico, C. Velasco, M. Ibba, A. Cilia, G. Motta, C. Riva, and A. Leonardi Effect of Several 5-Hydroxytryptamine1A Receptor Ligands on the Micturition Reflex in Rats: Comparison with WAY 100635 J. Pharmacol. Exp. Ther., September 1, 1999; 290(3): 1258 - 1269. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
